The consequences of glucocorticoid-activated GR signaling mediating protein expression related to tumor progression and drug resistance could influence patients with high endogenous cortisol levels or a susceptibility to GR signaling such as AA patients. The gene discussed is NR3C1; the disease is neoplasm.